• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
    • Cardiovascular
    • Orthopedics
  • Wall Street Beat
    • Funding Roundup
    • Mergers & Acquisitions
  • Podcasts & Webinars
    • Podcasts
    • Webinars
  • Resources
    • About MassDevice
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech 100 Index
    • Videos
    • Whitepapers
  • DeviceTalks Tuesdays
  • Coronavirus: Live updates

Covidien

The road to a robot: Medtronic’s development process for its Hugo RAS system

May 16, 2022 By Sean Whooley

Elephants are the perfect analogy for surgical robotics, Medtronic (NYSE:MDT) VP of Marketing for Surgical Robotics Mike Stow says. Speaking on the “Road to a robot: Designing technology to address unmet needs & barriers” panel at DeviceTalks Boston last week, Stow explained that elephants are big, taking up a lot of space and that they […]

Filed Under: Business/Financial News, Featured, Food & Drug Administration (FDA), Health Technology, News Well, Regulatory/Compliance, Robotics, Surgical, Urology Tagged With: Covidien, DeviceTalks Boston, Medtronic, Robotic Surgery, surgical robot

Medtronic’s recall of HawkOne system is Class I

January 21, 2022 By Sean Whooley

The FDA today issued a notice confirming that the recall of Medtronic’s (NYSE:MDT) HawkOne system is Class I, the most serious kind. So far in 2022, the FDA has classified three Medtronic-related recalls as Class I, with the Covidien (part of Medtronic) Puritan Bennett 980 series ventilator and the Synergy Cranial and StealthStation S7 Cranial […]

Filed Under: Blood Management, Catheters, Featured, Food & Drug Administration (FDA), News Well, Recalls, Regulatory/Compliance, Vascular Tagged With: Covidien, FDA, Medtronic

Medtronic’s Covidien recall of some Puritan Bennett ventilators is Class I

December 10, 2021 By Sean Whooley

The FDA confirmed that the recall of Medtronic’s (NYSE:MDT) Covidien unit’s Puritan Bennett ventilator is Class I, the most serious kind. Class I designations, the FDA’s most serious classification, are used when there is a reasonable probability that product use could cause serious adverse health consequences or death. Medtronic’s North Haven, Connecticut-based Covidien unit initiated […]

Filed Under: Featured, Recalls, Regulatory/Compliance, Respiratory Tagged With: Covidien, Medtronic, Puritan Bennett

DTW Podcast: Zimmer Biomet slims, Corza Medical grows in pursuit of grabbing market share

February 8, 2021 By Tom Salemi

In this week’s DeviceTalks Weekly Podcast, Rich Newitter, managing director at SVB Leerink, says Zimmer Biomet’s decision to spin out its spinal and dental business will accelerate its already impressive market share grab in its core orthopedics industry. Newitter says CEO Bryan Hanson brings a tried-and-true diversification model used by companies like his former employer, […]

Filed Under: Dental, Device Talks Podcasts, Digital Health, Featured, Lab Instruments & Supplies, Orthopedics, Spine, Surgical, Wall Street Beat Tagged With: 3m, Abbott, Abbott Laboratories, Aegea Medical, Boston Scientific, CooperSurgical, Corza Medical, Covidien, Medtronic, SVB Leerink, Zimmer Biomet

Feds target Medtronic in ventilator antitrust investigation

September 30, 2020 By Nancy Crotti

Medtronic (NYSE:MDT) is under investigation by the federal government for allegedly limiting competition in the ventilator business, the company acknowledged late yesterday. The civil antitrust probe grew out of complaints about device shortages during the coronavirus pandemic, according to a report by the Wall Street Journal. The Journal cited “people familiar with the matter” as saying […]

Filed Under: Business/Financial News, Featured, Legal News, Respiratory, Wall Street Beat Tagged With: Covidien, Medtronic, Medtronic buys Covidien, Newport Medical Instruments, U.S. Biomedical Advanced Research and Development Authority (BARDA), U.S. Department of Justice

Medtronic responds to NY Times story about failed ventilator contract

March 30, 2020 By Sean Whooley

Medtronic (NYSE:MDT) is providing additional facts in response to a New York Times report detailing an acquisition by Covidien that allegedly changed the course of a government contract designed to increase ventilator supply, now a major problem amid the coronavirus pandemic. Medtronic bought Covidien for $50 billion in 2015 — years after the events described in the […]

Filed Under: Business/Financial News, Contract Manufacturing, Featured, Food & Drug Administration (FDA), Mergers & Acquisitions, Regulatory/Compliance, Respiratory Tagged With: coronavirus, COVID-19, Covidien, FDA, Medtronic, Newport Medical Instruments

Medtronic’s Covidien to pay $20m to settle ClosureFast kickback allegations

March 13, 2019 By Fink Densford

Medtronic‘s (NYSE:MDT) Covidien has agreed to pay approximately $20 million to resolve kickback allegations related to the sale and promotion of its ClosureFast radiofrequency ablation catheters. The Fridley, Minn.-based company agreed to pay approximately $17.5 million to the U.S. to settle alleged violations of the False Claims Act and an additional $1.5 million to California […]

Filed Under: Business/Financial News, Featured, Legal News Tagged With: Covidien, Medtronic

Medtronic touts U.S. results of lung cancer detection trial

January 30, 2019 By Nancy Crotti

Partial results of a huge, real-world study of Medtronic’s (NYSE:MDT) superDimension LungGPS technology found that 65% of patients diagnosed with primary lung cancer (Stages I and II) were at early stages of the disease. Early detection of lung cancer is critical to improving patient outcomes long-term. The results came from a 12-month follow-up of the 1,215-patient […]

Filed Under: Clinical Trials, Featured, Oncology Tagged With: Covidien, journalofthoraciconcology, Medtronic

Medtronic asks judge to accept its negotiated $17.9m sentence in ev3 case

January 24, 2019 By Nancy Crotti

Medtronic (NYSE:MDT) wants the judge in its off-label marketing case against its neurovascular subsidiary ev3 to accept the sentence that the company and U.S. Justice Department have agreed upon. Medtronic agreed in December 2018 to plead guilty to a misdemeanor charge related to its marketing of the Onyx Liquid Embolic System, pay $17.9 million and adopt new […]

Filed Under: Legal News, Neurological Tagged With: Covidien, ev3 Inc., Medtronic

JenaValve names Kilcoyne as CEO | Personnel Moves – January 15, 2019

January 15, 2019 By Fink Densford

JenaValve Technology said today that it named former ReVision Optics prez & CEO John Kilcoyne as its new chief executive officer, effective immediately, replacing Dr. Victoria Carr-Brendell, who has taken up an executive leadership position with Sonova Holding AG (SIX:SOON). Prior to his time at ReVision Optics, Kilcoyne served as prez & CEO at Micrus Endovascular where he […]

Filed Under: Business/Financial News, Featured Tagged With: apyxmedical, biogennix, Cardiac Dimensions, Cardiovascular Systems Inc., Coorstek, Covidien, DaVita Inc., Digirad Corp., Endologix, ev3 Inc., Integra LifeSciences, Intuitive Surgical, InVivo Therapeutics, JenaValve, Johnson and Johnson, Medtronic, mentice, Micrus Endovascular Corp., Natus Medical Inc., Outset Medical, Patterson Companies, ReVision Optics Inc., Solace Therapeutics, Sonova Holding AG, Xtant Medical

Motus GI taps Moran as CEO | Personnel Moves – September 25, 2018

September 25, 2018 By Fink Densford

Motus GI said today that it named Timothy Moran as its new chief executive officer, effective October 1, replacing former CEO Mark Pomeranz who will assume the role of president and COO. Moran has previously served ConvaTec‘s (LON:CTEC) Americas president and helped lead the company through its initial public offering in 2016. Prior to ConvaTec, Moran spent […]

Filed Under: Business/Financial News Tagged With: Allurion Technologies, Baxter, biomedgps, Bristol-Myers Squibb Co., ConvaTec, Covidien, Integra LifeSciences, Lumicell, Mallinckrodt, MedX Health, MOTUS GI, Myomo Inc, National Institutes of Health (NIH), Natus Medical Inc., northstarmedicaltechnologies, Personnel Moves, Pursuit Vascular, ReWalk Robotics

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Interim pages omitted …
  • Go to page 59
  • Go to Next Page »

Primary Sidebar

DeviceTalks Weekly

July 1, 2022
Boston Scientific CEO Mike Mahoney on building a corporate culture that drives high growth results
See More >

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Need Medtech news in a minute?
We Deliver!

MassDevice Enewsletters get you caught up on all the mission critical news you need in med tech. Sign up today.

MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World

Device Talks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our Device Talks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us
Add us on Facebook Follow us on Twitter Connect with us on LinkedIn Follow us on YouTube

Copyright © 2022 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Advertise | Privacy Policy | RSS